AbbVies’s Rinvoq Trump for Crohn’s Disease
Synopsis: AbbVie’s blockbuster hopeful Rinvoq notched a win in a tricky-to-treat group of Crohn’s disease patients. The trial studied the AbbVie drug…
Synopsis: AbbVie’s blockbuster hopeful Rinvoq notched a win in a tricky-to-treat group of Crohn’s disease patients. The trial studied the AbbVie drug…
Synopsis : Vyera Pharmaceuticals has agreed to pay up to $40 million to settle charges that it engaged in anticompetitive practices to…
BELGRADE, Serbia – December 7, 2021 – Corteva Agriscience announced today that Serbia has approved the registration of a product with Inatreq™ active. Inatreq™ active…
MINUTES OF THE 434th REGISTRATION COMMITTEE MEETING HELD ON 30.11.2021. The 434th meeting of the Registration Committee (RC) was held under the…
The Cabinet Committee on Economic Affairs (CCEA) on Wednesday gave approval for committed price support of ₹17,408.85 crore to the Cotton Corporation…
Summary- The Indian Pharmacopoeia Commission (IPC) has added 9 new IP impurities standards which includes Bromhexine Hydrochloride Impurity C, Cabergoline Impurity A,…
Synopsis: A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is…
Synopsis: The MoU will facilitate development of QPM of medicinal plants and herbs identified by NMPB and help in establishment of their…
Summary – Bayer’s blockbuster hopes for Nubeqa just got a little brighter, thanks to a phase 3 trial win that could result…
Synopsis : DUSA Pharmaceuticals Inc has reached settlement with Biofrontera to resolve a litigation over misappropriation of trade secrets and unfair practice,…